Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, July 25, 2024

New Tool Shows Promise in Identifying Patients Who Need Post-Stroke Spasticity Care

 Why? You simply ask the patient if they have muscle stiffness and then tell them there is ABSOLUTELY NOTHING OUT THERE THAT WILL CURE SPASTICITY! Tell them they're screwed for the rest of their life. I've had spasticity for 18 years now and it hasn't lessened one bit.  Notice the word 'care' NOT CURE! Words matter!

New Tool Shows Promise in Identifying Patients Who Need Post-Stroke Spasticity Care

  • LinkedIn

  • Twitter

  • New Tool Shows Promise in Identifying Patients Who Need Post-Stroke Spasticity Care

    What You Should Know: 

    – Early detection and treatment of post-stroke spasticity (PSS) are essential for improving a patient’s ability to function and overall quality of life after a stroke. 

    – To address this need, AbbVie researchers developed the PSS Referral Tool to help clinicians involved in stroke rehabilitation identify and refer patients with PSS more quickly. A recent study investigated the reliability of this tool in a clinical setting.

    Study Design and Findings

    The researchers conducted a prospective study with three phases. In the first phase, they created standardized videos showing patients undergoing clinical assessments. In the second phase, a panel of PSS experts categorized the videos into different referral categories: urgent referral, routine referral, and periodic monitoring. Finally, in the third phase, the researchers recruited clinicians, including physical therapists, non-injecting physiatrists, and neurologists, from various regions around the world. These clinicians had no prior experience with the PSS Referral Tool and were trained on how to use it before classifying referral needs for patients in the videos.

    The researchers assessed inter-rater reliability using a statistical method called the intraclass correlation coefficient (ICC). This score indicates the level of agreement between the clinicians’ ratings. An ICC score closer to 1 reflects better agreement.

    The study recruited a total of 50 clinicians from various regions, with approximately 70% having no prior experience with the PSS Referral Tool. The overall ICC for clinician ratings was 0.68, indicating good reliability. The accuracy rates for different referral categories were as follows:

    • Urgent Referral: 69.2% (173/250)
    • Routine Referral: 69.2% (173/250)
    • Periodic Monitoring: 88.0% (220/250)

    Interestingly, even clinicians with no experience using the tool were able to correctly classify a high proportion of videos. Clinicians with and without experience correctly classified 14/15 and 13/15 videos, respectively, translating to sensitivity rates of 93.3% and 86.7%.

    No comments:

    Post a Comment